Long Acting Beta2-Agonists Drugs Market Segmentation Detailed Study with Forecast to 2025
Long-acting beta2-agonists are bronchodilators, a class of asthma medication, taken on a daily basis to relax the smooth muscle lining of bronchial tubes, the airways that carry air to the lungs. It allows the tubes to stay open for a longer period of time to help breathe easily. Long acting beta2-agonists are used to open narrow airways and prevent asthma attacks. These are used in dry powder or metered-dose inhalers. According to the FDA guidelines, long acting beta2-agonists should not...
View full press release